See also this year's filing and all EDGAR filings for this company.
PDF Report 0001828522_2023_eFFECTOR_Therapeutics_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) 2': 2, '100050 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)': 11}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001828522, eFFECTOR Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 28,014,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 241,000 |
| 3 | remainder_Assets | 822,000 |
| 4 | LiabilitiesCurrent | 25,075,000 |
| 5 | LiabilitiesNoncurrent | 60,000 |
| 6 | remainder_Liabilities | 46,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,643,000 |
| 9 | ResearchAndDevelopmentExpense | 23,313,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,553,000 |
| 12 | remainder_NetIncome | 9,738,000 |
| 13 | remainder_ComprehensiveNetIncome | -18,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 29,077,000 |
| 1 | Liabilities | 25,181,000 |
| 2 | Expenses | 35,956,000 |
| 3 | Revenues | 3,553,000 |
| 4 | StockholdersEquity | 3,896,000 |
| 5 | NetIncome | -22,665,000 |
| 6 | ComprehensiveNetIncome | -22,674,000 |
| 7 | BaseVar | 51,761,500 |
| 8 | EconomicCapitalRatio | -0.589 |
Edgar->Model Mapping
Feature Distribution
Change over Time
